New Pneumococcal Vaccine Approved by the U.S. FDA
July 21, 2021
Mountain Pacific
The U.S. Food and Drug Administration (FDA) just approved a new vaccine for adults. PREVNAR 20™ (Pneumococcal 20-valent Conjugate Vaccine) helps prevent invasive disease and pneumonia caused by the 20 Streptococcus pneumoniae (pneumococcus) serotypes, or subgroups, in the vaccine and is recommended for adults age 18 years and older. Pneumococcal disease can include pneumonia, meningitis […]
Read More...
